Business expansion
Border; Midland and Western; Border
Location of affected unit(s)
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

135 jobs
Number of planned job creations
Job creation
Announcement Date
12 May 2008
Employment effect (start)
Foreseen end date


Randox Laboratories, a clinical diagnostics company based in Northern Ireland, plans to create 135 new jobs in County Donegal, Ireland.

The announcement is part of a €7.5 million investment project to develop a manufacturing, research and development facility in Donegal. It is the first capital investment project in the Republic by the Antrim-based company, which employs more than 600 people in Northern Ireland.

Randox Laboratories' marketing manager said that the company decided to invest in the Republic because it had been frustrated over the level of support it received from economic development agencies in the North. "Our investment plans were being hampered by a high level of bureaucracy in Northern Ireland. Invest Northern Ireland were not as flexible as we had hoped they would be. We were approached by investment bodies from southern Ireland and we looked at investment opportunities which existed in Donegal." Mr Henry said that the company's decision had not been influenced by the Republic's more attractive corporation tax rate of 12.5 per cent, which compares to the North's 28 per cent.


  • 13 May 2008: The Irish Times


Eurofound (2008), Randox Laboratories, Business expansion in Ireland, factsheet number 66618, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/66618.